Drugs Made IN America Acquisition Corp (DMAA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DMAA | ||||
| Company | Drugs Made IN America Acquisition Corp | ||||
| Price Information | |||||
| Exchange | NASDAQ | ||||
| Open | 10.62 | ||||
| High | 10.62 | ||||
| Low | 10.61 | ||||
| Latest | 10.61 | ||||
| Change | +0.01 | ||||
| % Change | +0.05% | ||||
| Volume | 500 | ||||
| 20-Day Average Volume | 46,770 | ||||
| Previous Close | 10.61 | ||||
| Industry | Unclassified | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 10.60 | ||||
| 20-Day Raw Stochastic | 87.50% | ||||
| 20-Day Relative Strength | 60.78 | ||||
| Weighted Alpha | +4.38 | ||||
| Today's Opinion | 100% Buy | ||||
| Previous Opinion | 100% Buy | ||||
| Last Month's Opinion | 100% Buy | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.05% since 06/05/26 | ||||
| Low | 10.60 on 06/09/26 | ||||
| High | 10.62 on 06/12/26 | ||||
| 1-Month | |||||
| %Chg | +0.14% since 05/12/26 | ||||
| Low | 10.58 on 05/19/26 | ||||
| High | 10.62 on 06/12/26 | ||||
| 3-Month | |||||
| %Chg | +1.38% since 03/10/26 | ||||
| Low | 10.47 on 03/18/26 | ||||
| High | 10.62 on 06/12/26 | ||||
| 6-Month | |||||
| %Chg | +2.54% since 12/12/25 | ||||
| Low | 10.35 on 12/17/25 | ||||
| High | 10.62 on 06/12/26 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | 257,700 | ||||
| Shares Outstanding, K | 24,277 | ||||
| Annual Sales | 0 | ||||
| Annual Net Income | 5,940,643 | ||||
| Last Quarter Sales | 0 | ||||
| Last Quarter Net Income | 1,970,459 | ||||
| 60-Month Beta | 0.01 | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 05/14/26 | ||||
| Earnings Date | N/A | ||||
| Most Recent Dividend | N/A | ||||
| Next Ex-Dividends Date | N/A | ||||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | ||||